tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Naz Rahman, 19 are a BUY (82.61%), 4 are a HOLD (17.39%).
Analyst Naz Rahman, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 22.22% that have a potential upside of 14.69% achieved within 32 days.
Naz Rahman’s has documented 39 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on SCPH, Scpharmaceuticals at 20-Mar-2025.
Analyst best performing recommendations are on PALI (PALISADE BIO).
The best stock recommendation documented was for PALI (PALISADE BIO) at 3/30/2023. The price target of $50 was fulfilled within 1 day with a profit of $10.25 (25.79%) receiving and performance score of 257.86.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 7 months 10 days ago
(23-Aug-2022)
0/1 (0%)
$8.35 (228.77%)
Hold
$13
2 years 7 months 11 days ago
(22-Aug-2022)
0/1 (0%)
$8.7 (202.33%)
Buy
$10
2 years 10 months 16 days ago
(17-May-2022)
0/1 (0%)
$4.78 (91.57%)
Buy
$12
2 years 11 months 22 days ago
(11-Apr-2022)
0/1 (0%)
$3.91 (48.33%)
Buy
$20
2 years 11 months 22 days ago
(11-Apr-2022)
0/1 (0%)
$11.91 (147.22%)
Which stock is Naz Rahman is most bullish on?
Which stock is Naz Rahman is most reserved on?
What Year was the first public recommendation made by Naz Rahman?
